US Stocks
/
Arcutis Biotherapeutics, Inc. Share Price

Arcutis Biotherapeutics, Inc. Share Price

NASDAQ: ARQT | Mid Cap
$25.37
-$1.14 (-4.3%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Arcutis Biotherapeutics, Inc. Stock Performance

Open
$26.45
Prev. Close
$26.51
Circuit Range
N/A
Day Range
$25.17 - $26.66
Year Range
$16.68 - $31.75
Volume
3,46,195
Average Traded
$25.72

Arcutis Biotherapeutics, Inc. Share Price Today

As of 19 September 2026, Arcutis Biotherapeutics, Inc.'s share price is $25.37. The stock opened at $26.45, compared to its previous close of $26.51. During today's trading session, Arcutis Biotherapeutics, Inc.'s share price traded between $25.17 and $26.66, with an average price of $25.91. Over the past 52 weeks, the stock has recorded a high of $31.75 and a low of $16.68. In terms of performance, Arcutis Biotherapeutics, Inc.'s share price has risen by 7.61% over the last six months and is up 34.59% on a year-on-year basis.

Arcutis Biotherapeutics, Inc. Share Price Chart

$25.17$26.66
L
Show Current Price
H

Arcutis Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.23B
PE Ratio (TTM)
-195.15
Dividend Yield
N/A
EPS (TTM)
$-0.13
Revenue (TTM)
$376.07M
Return On Equity (TTM)
-8.52%
Profit Margin
-4.29%
Debt to Equity
0.69
Quarterly Earnings Growth YoY
N/A

About Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE foam for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-255, a selective small molecule inhibitor of JAK1 for the treatment of alopecia areata; ARQ-252, a JAK1-selective topical cream in development for hand eczema and vitiligo; and ARQ-234, a CD200R fusion protein for the treatment of atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Arcutis Biotherapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$24.00
$25.34
+1.91%
Aug 2026
$26.39
$24.86
-7.41%
Jul 2026
$26.35
$26.86
+2.30%
Jun 2026
$21.30
$26.25
+22.21%
May 2026
$23.12
$21.48
-7.45%
Apr 2026
$23.80
$23.21
-1.55%
Mar 2026
$25.90
$23.57
-12.59%
Feb 2026
$25.02
$26.97
+6.18%
Jan 2026
$28.89
$25.40
-12.53%
Dec 2025
$30.14
$29.04
-5.27%
Nov 2025
$25.20
$30.66
+21.07%
Oct 2025
$18.86
$25.32
+34.32%

ARQT Share Price FAQs

What is Arcutis Biotherapeutics, Inc. share price today?

chevron-up
Arcutis Biotherapeutics, Inc. share price today is $25.37 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Arcutis Biotherapeutics, Inc. stock?

chevron-up
The 52 week high of Arcutis Biotherapeutics, Inc. stock is $31.75, while the 52 week low is $16.68 as of 19 Sep '26.

What is ARQT's market capitalisation today?

chevron-up
ARQT market capitalisation is $3.23B as of September 19, 2026, at 4:45 am IST.

What is the 5 year returns of ARQT?

chevron-up
The 5 year returns of ARQT is 5.77% as on 19 Sep '26.

What is the high & low stock price of ARQT today?

chevron-up
ARQT stock price hit a high of $26.66 and low of $25.17 as of 19 Sep '26.

Can I buy ARQT shares in India?

chevron-up
Yes. You can buy ARQT in India by opening an international trading account.